# Intralipid for Recurrent Miscarriage

> **NCT01788540** · PHASE4 · COMPLETED · sponsor: **Woman's Health University Hospital, Egypt** · enrollment: 300 (estimated)

## Conditions studied

- Abortion, Spontaneous
- Abortion, Habitual

## Interventions

- **DRUG:** Intralipid

## Key facts

- **NCT ID:** NCT01788540
- **Lead sponsor:** Woman's Health University Hospital, Egypt
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2016-08
- **Final completion:** 2016-09
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2018-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01788540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01788540, "Intralipid for Recurrent Miscarriage". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01788540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*